Research report: QRISK3 Assessment Identified Essential Thrombocythemia Patients at High Risk of Thrombotic Events Regardless of Revised IPSET‐T Score and JAK2 Mutational Status
A cardiovascular risk calculator flagged hidden clot danger in blood cancer patients whom standard age-based tools classified as low risk.
